PepGen

Biotechnology Research • Boston, Massachusetts, United States • 51-100 Employees

Company overview

Headquarters	321 Harrison Ave, 8th Floor, Boston, Massachusetts 02118, US
Phone number	+441865618820
Website	pepgen.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Life Sciences, Chemistry, Biology, Therapeutics, Bioscience
Founded	2018
Employees	51-100
Socials

Key Contacts at PepGen

James Mcarthur

Chief Executive Officer

Aditya Patil

Associate Director, Quality System

Forum Sanghvi

Senior Director, Global Regulatory Strategy Lead

Mitchell H Finer

Member Board Of Directors

Diana Sinclair

Associate Director Quality Control

Laurie Keating

Chair Of The Board Of Directors

Sarah Vacca

Senior Director, Head Of Clinical Operations

Ashling Holland

Director, Research & Preclinical Development

Deborah Lucas

Director, Clinical Data Management

Hongling Han

Senior Director, Head Of Analytical Development & Qc

PepGen Email Formats

PepGen uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@pepgen.com), used 63.3% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@pepgen.com	63.3%
{first name}{last name}	johndoe@pepgen.com	31.7%
{last name}{last name}	doedoe@pepgen.com	5%

About PepGen

Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.

PepGen revenue & valuation

Annual revenue	$7,500,000
Revenue per employee	$108,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$24,000,000
Total funding	No funding